FDA.reportPublic FDA data

Alphagan P 0.15 % Ophthalmic Solution

RxCUI
861210
RxNorm name
Alphagan P 0.15 % Ophthalmic Solution
Display name
Alphagan P 0.15 % Ophthalmic Solution
Full name
Alphagan P 0.15 % Ophthalmic Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:50

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ALPHAGAN PBRIMONIDINE TARTRATEAllergan, Inc.264c4494-c225-486f-888a-caaf36be46b32025-09-18Warnings, Adverse reactionsExact identifier
rxcui: 861210

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
264c4494-c225-486f-888a-caaf36be46b3Alphagan P 0.15 % Ophthalmic Solution [PSN] · brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [Alphagan] [SBD] · Alphagan 1.5 MG/ML Ophthalmic Solution [SY] · Alphagan P 0.15 % Ophthalmic Drops [SY]424These highlights do not include all the information needed to use ALPHAGAN P safely and effectively. See full prescribing information for ALPHAGAN P. ALPHAGAN ® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% , for topical ophthalmic use Initial U.S. Approval: 199620250918
ba15fa83-c808-4298-bb0e-43ed1429c526Alphagan P 0.15 % Ophthalmic Solution [PSN] · brimonidine tartrate 1.5 MG/ML Ophthalmic Solution [Alphagan] [SBD] · Alphagan 1.5 MG/ML Ophthalmic Solution [SY] · Alphagan P 0.15 % Ophthalmic Drops [SY]44These highlights do not include all the information needed to use ALPHAGAN ® P safely and effectively. See full prescribing information for ALPHAGAN ® P. ALPHAGAN ® P (brimonidine tartrate ophthalmic solution) 0.1% and 0.15% Initial U.S. Approval: 199620130315